載入...
2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems
BACKGROUND: Infections due to extended spectrum β-lactamase (ESBL) producing bacteria are problematic due to the association with worse outcomes and limited treatment options. Carbapenems (CBPs) remain the drugs of choice for these infections due to evidence of a mortality benefit and the mixed clin...
Na minha lista:
| 發表在: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6255585/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.2095 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|